Schedule 13D ownership disclosure

Y-MABS THERAPEUTICS INC

Security class unavailable · CUSIP: 984241109

Event date: 2018-09-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,104,278
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-052038
Form type
SC 13D
Filer
Sofinnova Venture Partners X, L.P.
CIK
CIK 1680200
Filed
Oct 02, 2018
Reporting period
Sep 21, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub